重复剂量毒性和免疫原性评估的复合子单位COVID-19疫苗 (ZF2001) 在老鼠中

相关实验视频

Updated: Jun 23, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

42.6K

Ruimin Sun1,2, Lijuan Xia1,2, Guangbiao She3,4

  • 1Key Laboratory of Drug Safety Evaluation and Research of Zhejiang Province, Center of Safety Evaluation and Research, Hangzhou Medical College, Hangzhou, China.

Frontiers in cellular and infection microbiology
|May 7, 2025
PubMed
概括

针对SARS-CoV-2的ZF2001蛋白质子单位疫苗在斯普拉格·道利大鼠中证明了安全性和免疫性. 它没有显著的系统毒性,并诱导了保护性IgG抗体,支持其用于抗击COVID-19.

关键词:
在 COVID-19 疫情中,在 ZF2001 里,你会看到 ZF2001 .免疫反应的免疫反应.重复剂量毒性研究亚单元蛋白质疫苗的疫苗

更多相关视频

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue09:42

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

11.4K
In Vitro ELISA Test to Evaluate Rabies Vaccine Potency09:04

In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

Published on: May 11, 2020

12.3K

相关概念视频

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...